Clinically Isolated Syndrome (CIS) Market is segmented By Treatment (Systemic Treatments, Primary Therapy, Primary Therapy, Recurrence Therapy, Recurrence Therapy), By Emerging Drugs, (Olvimulogene nanivacirepvec, Rucaparib), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Clinically Isolated Syndrome (CIS) Market is segmented By Treatment (Systemic Treatments, Primary Therapy, Primary Therapy, Recurrence Therapy, Recurr....